Wells Fargo has revised its price target for Clorox (CLX, Financial), reducing it from $155 to $145. This change comes as the firm maintains its Equal Weight rating on the company's shares. The adjustment is part of a broader review of their global sell-in/sell-through framework ahead of the upcoming earnings report.
The U.S. market data, which will soon be finalized, is expected to heighten concerns about consumer spending trends. Despite these anticipated challenges in the domestic market, emerging market data appears to provide some positive influence for multinational corporations like Clorox.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Clorox Co (CLX, Financial) is $157.54 with a high estimate of $189.00 and a low estimate of $134.00. The average target implies an upside of 12.96% from the current price of $139.46. More detailed estimate data can be found on the Clorox Co (CLX) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, Clorox Co's (CLX, Financial) average brokerage recommendation is currently 3.0, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Clorox Co (CLX, Financial) in one year is $148.54, suggesting a upside of 6.51% from the current price of $139.46. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Clorox Co (CLX) Summary page.
